United States (US) Advanced Therapy Medicinal Products Market (2025-2031) | Value, Growth, Competitive Landscape, Size & Revenue, Trends, Share, Outlook, Industry, Forecast, Segmentation, Analysis, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Advanced Therapy Medicinal Products Market - Industry Life Cycle

3.4 United States (US) Advanced Therapy Medicinal Products Market - Porter's Five Forces

3.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume Share, By Phase, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the US leading to the demand for advanced therapy medicinal products

4.2.2 Growing investments in research and development for advanced therapies in the US

4.2.3 Favorable regulatory environment supporting the development and commercialization of advanced therapy medicinal products

4.3 Market Restraints

4.3.1 High cost associated with advanced therapy medicinal products limiting accessibility for patients

4.3.2 Complex manufacturing processes and stringent regulatory requirements leading to longer time to market

4.3.3 Limited awareness among healthcare providers and patients about the benefits and availability of advanced therapy medicinal products

6.1 United States (US) Advanced Therapy Medicinal Products Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.1.4 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.1.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Tissue Engineered, 2021- 2031F

6.1.6 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Advanced Therapy Medicinal Products Market, By Phase

6.2.1 Overview and Analysis

6.2.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase I, 2021- 2031F

6.2.3 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase II, 2021- 2031F

6.2.4 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase III, 2021- 2031F

6.2.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase IV), 2021- 2031F

7.1 United States (US) Advanced Therapy Medicinal Products Market Export to Major Countries

7.2 United States (US) Advanced Therapy Medicinal Products Market Imports from Major Countries

8.1 Number of clinical trials and research studies conducted on advanced therapy medicinal products in the US

8.2 Adoption rate of advanced therapy medicinal products by healthcare facilities and providers

8.3 Patient outcomes and success rates following treatment with advanced therapy medicinal products

9.1 United States (US) Advanced Therapy Medicinal Products Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Advanced Therapy Medicinal Products Market Opportunity Assessment, By Phase, 2021 & 2031F

10.1 United States (US) Advanced Therapy Medicinal Products Market Revenue Share, By Companies, 2024

10.2 United States (US) Advanced Therapy Medicinal Products Market Competitive Benchmarking, By Operating and Technical Parameters